These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15757200)

  • 1. Analysis of P53 and P21WAF1 proteins expression in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Sałacińska-Loś E; Kulig A; Włoch J
    Pol J Pathol; 2004; 55(4):133-41. PubMed ID: 15757200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of P161NK4A protein expression in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Sałacińska-Loś E; Kulig A; Włoch J
    Pol J Pathol; 2004; 55(4):143-8. PubMed ID: 15757201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J
    Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Włoch J; Sałacińska-Los E; Kulig A; Jarzab B
    Pol J Pathol; 2004; 55(4):149-53. PubMed ID: 15757202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localisation of RET and p53 mutant protein of thyroid lesions in a North-Eastern Malaysian population and its prognostic implications.
    Omar E; Madhavan M; Othman NH
    Pathology; 2004 Apr; 36(2):152-9. PubMed ID: 15203751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic significance of selected oncogene and suppressor gene expression in follicular thyroid carcinoma].
    Lange D; Ferenc T; Niewiadomska H; Włoch J; Turska M; Burkacka J; Kula D; Lewiński A; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():72-8. PubMed ID: 12182065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. bcl2, p53 and bax in thyroid tumors and their relation to apoptosis.
    Farid P; Gomb SZ; Péter I; Szende B
    Neoplasma; 2001; 48(4):299-301. PubMed ID: 11712682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
    Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RET and p53 expression in thyroid follicular adenoma: a study of 52 cases with 14 years follow-up.
    Othman NH; Omar E; Mahmood MH; Madhavan M
    Malays J Pathol; 2005 Dec; 27(2):91-8. PubMed ID: 17191391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical analysis of cyclin D1, p53, and p21waf1/cip1 proteins in tumors originating from the follicular epithelium of the thyroid gland.
    Goto A; Sakamoto A; Machinami R
    Pathol Res Pract; 2001; 197(4):217-22. PubMed ID: 11358005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma.
    Jakubiak-Wielganowicz M; Kubiak R; Sygut J; Pomorski L; Kordek R
    Pol J Pathol; 2003; 54(2):111-5. PubMed ID: 14575419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of MIB-1 immunoreactivity and nucleolar organizer regions in nonneoplastic and neoplastic thyroid lesions.
    Lewy-Trenda I; Bieńkiewicz M
    Pol J Pathol; 1999; 50(3):129-38. PubMed ID: 10624114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
    Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
    Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of p53, CD44V6 and CD57 in differentiating between benign and malignant follicular neoplasms of the thyroid.
    Nasir A; Catalano E; Calafati S; Cantor A; Kaiser HE; Coppola D
    In Vivo; 2004; 18(2):189-95. PubMed ID: 15113046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.
    Gustafson KS; LiVolsi VA; Furth EE; Pasha TL; Putt ME; Baloch ZW
    Am J Clin Pathol; 2003 Aug; 120(2):175-81. PubMed ID: 12931546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta Np73 expression in thyroid neoplasms originating from follicular cells.
    Ito Y; Uramoto H; Funa K; Yoshida H; Jikuzono T; Asahi S; Higashiyama T; Tomoda C; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    Pathology; 2006 Jun; 38(3):205-9. PubMed ID: 16753740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of protein p53: the marker of low neoplastic cell differentiation in thyroid carcinoma].
    Szybiński P; Nowak W; Stachura J; Nowak K; Przybylik-Mazurek E; Buziak-Bereza M
    Wiad Lek; 2001; 54 Suppl 1():88-94. PubMed ID: 12182067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.